These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2155053)

  • 61. Neuron-specific enolase in neuroendocrine tumors of the thymus, bronchus, and skin.
    Wick MR; Scheithauer BW; Kovacs K
    Am J Clin Pathol; 1983 Jun; 79(6):703-7. PubMed ID: 6303108
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuron-specific enolase as a tumor marker in metastatic melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Serum neuron-specific enolase in small cell bronchial cancers].
    Milleron B; Cadranel J; Dominique S; Rosencher L; Akoun G
    Rev Pneumol Clin; 1990; 46(4):161-5. PubMed ID: 1966028
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Changes to levels of serum neuron-specific enolase in a patient with small cell carcinoma of the pancreas.
    Nakamura Y; Tajiri T; Uchida E; Arima Y; Aimoto T; Katsuno A; Naito Z
    J Hepatobiliary Pancreat Surg; 2005; 12(1):93-8. PubMed ID: 15754108
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.
    van Zandwijk N; Jassem E; Bonfrer JM; Mooi WJ; van Tinteren H
    Semin Oncol; 1992 Feb; 19(1 Suppl 2):37-43. PubMed ID: 1329221
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Treatment monitoring of patients with small cell lung cancer by determining levels of serum neuron specific enolase].
    Jassem E
    Pneumonol Alergol Pol; 1993; 61(1-2):56-60. PubMed ID: 8388760
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neuron-specific enolase: a serum tumor marker in renal cell carcinoma?
    Gross AJ; Michl UH; Bornhöft G; Dieckmann KP
    Eur Urol; 1993; 24(3):397-9. PubMed ID: 8262110
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
    Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
    Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Circulating neuron-specific enolase in medullary thyroid cancer.
    Pacini F; Elisei R; Anelli S; Gasperini L; Schipani E; Pinchera A
    Int J Biol Markers; 1986; 1(2):85-8. PubMed ID: 3429944
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Primary small-cell bronchial cancer: value of serum tumor markers in the prognostic evaluation].
    Watine J; Charet JC
    Presse Med; 1999 Sep; 28(28):1541-6. PubMed ID: 10526565
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
    Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    Naito A; Taguchi S; Nakagawa T; Matsumoto A; Nagase Y; Tabata M; Miyakawa J; Suzuki M; Nishimatsu H; Enomoto Y; Takahashi S; Okaneya T; Yamada D; Tachikawa T; Minowada S; Fujimura T; Fukuhara H; Kume H; Homma Y
    World J Urol; 2017 Jan; 35(1):97-103. PubMed ID: 27180266
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
    Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
    Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The value of tumour markers in lung cancer.
    Gomm SA; Keevil BG; Thatcher N; Hasleton PS; Swindell RS
    Br J Cancer; 1988 Dec; 58(6):797-804. PubMed ID: 2906254
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Neuron-specific enolase (NSE) in serum. Comparison of monoclonal versus polyclonal assay based on 392 blood samples.
    Drivsholm L; Osterlind K; Cooper EH; Purves DA
    Int J Biol Markers; 1995; 10(1):1-4. PubMed ID: 7629420
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Significance of neuron-specific enolase (NSE) in the diagnosis of bronchial carcinomas and neuroendocrine tumors].
    Fischbach W; Jany B; Nelkenstock R
    Dtsch Med Wochenschr; 1986 Nov; 111(45):1721-5. PubMed ID: 3023003
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer.
    Sunaga N; Tsuchiya S; Minato K; Watanabe S; Fueki N; Hoshino H; Makimoto T; Ishihara S; Saito R; Mori M
    Oncology; 1999; 57(2):143-8. PubMed ID: 10461062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Serum neuron specific enolase: can it be a tumour marker for renal cell carcinoma?
    Yaman O; Baltaci S; Arikan N; Ozdiler E; Göğüş O; Müftüoğlu YZ
    Int Urol Nephrol; 1996; 28(2):207-10. PubMed ID: 8836790
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Level of carcinoembryonic antigen, neuron-specific enolase and ferritin in serum of small cell lung cancer patients: correlation with performance status, disease extent and prognosis].
    Szturmowicz M; Rogińska E; Roszkowski K; Kwiek S; Filipecki S; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1993; 61(9-10):467-73. PubMed ID: 8111322
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Neuron-specific enolase in bronchial carcinoma. Immunohistochemical and immunoenzyme study].
    Leonardo E; Dogliotti C; Oliaro A
    Minerva Med; 1986 May; 77(22-23):977-80. PubMed ID: 3014380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.